This increased expression of antiviral genes correlated with reduced ZIKV RNA replication at late time point after infection that could be restored upon treatment of cells with ruxolitinib, an inhibitor of JAK/STAT signaling (Fig. 2D). The gene discussed is SOAT1; the disease is infection.